Tauriga Sciences, Inc. Completes Payment for the Entirety of its Initial Production Run of its Cannabigerol Infused Version o...
March 24 2020 - 1:55PM
InvestorsHub NewsWire
Tauriga Sciences, Inc. Completes
Payment for the Entirety of its Initial Production Run of its
Cannabigerol Infused Version of Tauri-Gum
The Company’s Initial Production Run
Totals 8,750 Blister Packs of Peach-Lemon Flavor – Cannabigerol
(“CBG”) Infused Version of Tauri-Gum™
NEW YORK, NY -- March 24, 2020 -- InvestorsHub NewsWire --
Tauriga Sciences, Inc. (OTCQB: TAUG)
(“Tauriga” or the “Company”), a revenue generating Company that
operates through the development, distribution, and licensing of
proprietary products as well as the evaluation of potential
acquisition opportunities and equity investments, today announced
that it has completed payment for the entirety of its initial
production run of its Cannabigerol (“CBG”) infused version of
Tauri-Gum™. The Company’s initial production run totals 8,750
blister packs (875 Retail Boxes) and there have already been a
number of customer orders via its E-Commerce website (www.taurigum.com). The
Company has experienced strong levels of interest (from a broad
array of prospective customers) for its Peach-Lemon flavor CBG
infused Tauri-Gum™: MSRP has been set @ $19.99 per Blister
Pack.
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG)
is a revenue generating Company that operates through the
development, distribution, and licensing of proprietary products as
well as the evaluation of potential acquisition opportunities. One
such opportunity on which the Company has acted, involves the
Company having entered into the cannabidiol (or “CBD”) infused
chewing gum product business, as more fully described above and in
prior press releases. This CBD infused chewing gum product
has been branded under the following name:
Tauri-Gum™. The Company is currently in production of
three distinct flavors of Tauri-Gum™: MINT, BLOOD ORANGE, and
POMEGRANATE. On December 6, 2019 the Company announced that
it completed the initial production run (thereby expanding its
existing product lines) with the introduction of a 25mg Vegan CBD
Isolate Infused vegan gummy (“gum drop”), branded under the name:
Tauri-Gummies™. Further, the Company continues to identify
and evaluate additional potential opportunities to generate
revenue, as well as shareholder value, and leverage its resources
and expertise to build a diversified and sustainable business
model. Please visit our corporate website at www.tauriga.com.
The Company has also announced the development of a Cannabigerol
(“CBG”) Isolate infused version of Tauri-Gum™. The flavor
that has been selected is Starfruit/Peach and each piece of gum
will contain 10mg of CBG Isolate / Each blister pack will contain
80mg of CBG Isolate. The Company expects to commence
production during its 4th Fiscal Quarter of 2020
(January 1, 2020 – March 31, 2020).
In addition, on March 11, 2019, the Company announced the
official launch of its E-Commerce site - as part of its Tauri-Gum™
commercialization strategy. This site can be accessed by
visiting the following URL address: www.taurigum.com
The Company has established corporate offices in both New York
City (USA) and Barcelona (Spain).
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements”
as defined by the Private Securities Litigation Reform Act of 1995
which represent management’s beliefs and assumptions concerning
future events. These forward-looking statements are often indicated
by using words such as “may,” “will,” “expects,” “anticipates,”
believes, “hopes,” “believes,” or plans, and may include statements
regarding corporate objectives as well as the attainment of certain
corporate goals and milestones. Forward-looking statements are
based on present circumstances and on management’s present beliefs
with respect to events that have not occurred, that may not occur,
or that may occur with different consequences or timing than those
now assumed or anticipated. Actual results may differ materially
from those expressed in forward looking statements due to
known and unknown risks and uncertainties, such as are not
guarantees of general economic and business conditions, the ability
to successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful
acquisition and licensing transactions, fluctuations in exchange
rates, and other factors over which Tauriga has little or no
control. Many of these risks and uncertainties are discussed in
greater detail in the “Risk Factors” section of Tauriga’s Form 10-K
and other filings made from time to time with the Securities and
Exchange Commission. Such forward-looking statements are made only
as of the date of this release, and Tauriga assumes no obligation
to update forward-looking statements to reflect subsequent events
or circumstances. You should not place undue reliance on these
forward-looking statements.
Contact:
CONTACT INFORMATION
Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2023 to Apr 2024